Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06210711 · ClinicalTrials.gov registry record · NA
Trauma BPE Prolonged Exposure Therapy for Injured Individuals Admitted to a Level I Trauma Center
A NA study of Post Traumatic Stress Disorder and PTSD, sponsored by Baylor Research Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 300
- Enrollment target
- 3
- Study locations
NCT06210711: Recruiting NA study of Post Traumatic Stress Disorder and PTSD, sponsored by Baylor Research Institute.
NCT06210711 is a NA study of Post Traumatic Stress Disorder and PTSD that is actively recruiting participants, run by Baylor Research Institute. The registered enrollment target is 300 participants, below the 663-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (55% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06210711, a NA study of Post Traumatic Stress Disorder and PTSD, is actively recruiting participants, sponsored by Baylor Research Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this research is to determine if a brief treatment method is effective for preventing posttraumatic stress disorder (PTSD) and a number of other concerns following injury.
Primary Outcome
The CAPS-5 is a 30-item, structured interview that assesses PTSD symptoms and makes a diagnostic determination based on the DSM-5 criteria and is considered the gold standard of PTSD assessment. Questions assess for PTSD symptoms corresponding to the 4 DSM-5 clusters of re-experiencing, avoidance, changes in mood and cognition, and arousal and hyperactivity, and includes questions on duration, impact of symptoms, distress and impact of symptoms on social and occupational functioning. The intervi
Conditions Studied
Interventions
- BEHAVIORAL Treatment as Usual
- BEHAVIORAL Brief Prolonged Exposure Therapy
Study Locations (3)
Texas
- Baylor University Medical Center - Dallas
- Baylor Scott & White Medical Center - Temple - Temple
Wisconsin
- Froedtert & Medical College of Wisconsin - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2024-02-28 |
| Est. Completion | 2027-09 |
| Phase | NA |
What NCT06210711 shows while recruiting
NCT06210711 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 663-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (55% lower).
The record links to 3 conditions, with Post Traumatic Stress Disorder appearing as the primary indexed condition, and to 2 interventions - of which Treatment as Usual is the first listed.
NCT06210711 reports a single indexed study location in Texas, Wisconsin.
Frequently Asked Questions
What is clinical trial NCT06210711 about?
NCT06210711 is a clinical study titled "Trauma BPE Prolonged Exposure Therapy for Injured Individuals Admitted to a Level I Trauma Center". The purpose of this research is to determine if a brief treatment method is effective for preventing posttraumatic stress disorder (PTSD) and a number of other concerns following injury.
What is the current status of trial NCT06210711?
This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2024-02-28. Estimated completion is 2027-09.
What conditions does trial NCT06210711 study?
This clinical trial studies the following conditions: Post Traumatic Stress Disorder, PTSD, Traumatic Injury.
What interventions are being tested in trial NCT06210711?
The interventions under investigation include: Treatment as Usual (BEHAVIORAL), Brief Prolonged Exposure Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT06210711?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06210711 being conducted?
This trial has 3 study locations across Texas, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Post Traumatic Stress Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06210711's enrollment target sits among peer trials
300 28th of 262 higher than 230 of 262 other Post Traumatic Stress Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Post Traumatic Stress Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
CRISOL Mente: A Multilevel Community Intervention to Reduce Mental Health Disparities Among Latinos
RECRUITING · NA
-
TMS-fNIRS Personalized Dosing
RECRUITING · NA
-
Targeting the Default Mode Network: A TMS-fMRI Study
RECRUITING · NA
-
The Effects of Very Brief Exposure on PTSD in U.S. Combat Veterans
RECRUITING · NA
-
Fear and Avoidance in PTSD Patients
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI